Pennington Biomedical Research Center

Pennington Biomedical Research Center, a Louisiana State University-affiliated 1862 Land Grant College research institution based in Baton Rouge, Louisiana, provides specialized biochemistry analysis services and conducts federal biomedical research as a prime recipient on federal grants and a prime contractor on a single-award Army Medical Command indefinite delivery contract. The center operates as a state government entity with no SBA set-aside designations and competes in full-and-open procurements. Pennington's federal footprint centers overwhelmingly on the National Institutes of Health and the Department of the Army, with 78% of recent awards held as prime and 22% as sub-awards or sub-grants.

Pennington's prime contract work focuses on biochemistry analysis services. The U.S. Army Medical Command holds a $7.835 million single-award IDC awarded September 18, 2024, and extending through September 2029, under which Pennington delivers analysis of biological samples to measure nutritional and metabolic biomarkers, vitamin D analysis, and related biochemical measurements in support of Army medical research. Recent delivery orders under this IDC range from $3,260 to $279,712 in ceiling value, with work performed at Pennington's main facility in Baton Rouge and at secondary locations including Natick, Massachusetts (the U.S. Army Research Institute of Environmental Medicine). The Army Medical Command accounts for 37 awards with $29.2 million in combined potential value and dominates the customer concentration landscape—all other federal funding sources combined account for a negligible portion of the contract dollar base. Additional contract work includes smaller delivery orders from the Defense Health Agency for biochemistry analysis services valued under $25,000 each.

Pennington's federal footprint is anchored by a robust grant portfolio with the National Institutes of Health. The top funding agencies are the National Institute of Diabetes and Digestive and Kidney Diseases (59 awards as prime recipient), the National Institute on Aging (22 awards), and the Office of the Director (16 awards), with additional funding from the National Institute of Child Health and Human Development, the National Heart Lung and Blood Institute, the National Institute of General Medical Sciences, the National Cancer Institute, the National Institute for Minority Health and Health Disparities, and the National Center for Complementary and Integrative Health. Recent NIH grants (all awards above the $150,000 reporting threshold, awarded fiscal 2024–2026) include a $2.0 million project grant for acquisition and installation of a 3-Tesla Siemens Vida MRI system (CFDA 93.351, Office of the Director, FY2025); a $783,680 project grant examining metal mixtures, epigenome, adiposity, and cardiometabolic risk across early life (CFDA 93.847, NIDDK, FY2025); a $769,097 project grant investigating a novel brain-to-pancreatic islet neural circuit regulating glucose homeostasis (CFDA 93.847, NIDDK, FY2025); a $749,481 project grant for a lifestyle intervention study to improve muscle function in older adults with obesity and insulin resistance (CFDA 93.866, National Institute on Aging, FY2026); and a $187,500 project grant on supplementation strategy to prevent neural tube defects (CFDA 93.865, NICHD, FY2025). Pennington also holds cooperative agreements including a multi-year $13.146 million award for the Center for Military Performance and Resilience (Defense Health Agency, funded through FY2026) and a Louisiana Nutrition for Precision Health clinical center cooperative agreement operating through FY2026. Grant work spans obesity, diabetes, nutrition, metabolism, aging, cardiometabolic disease, birth defects, cancer survivorship, and basic neuroscience.

Activity has grown year-over-year, from 16 awards in 2022 to a peak of 35 in 2024, with 30 awards in 2025 and 8 recorded awards in 2026 (early-year snapshot). Twenty-seven awards with combined potential value of $146,000 reach ultimate completion within the next twenty-four months, representing a modest recompete exposure. The bulk of this near-term completions are small-value, short-duration Army biochemistry analysis delivery orders.

Pennington operates as a prime recipient on 78% of awards and as a sub-recipient on 22%, serving as a research partner on larger multi-site consortia. Named sub-award prime grantees include Adventist Health System (multiple cardiovascular and metabolic research studies), University of Hawaii (dietary assessment methods for personalized nutrition), Trustees of Tufts College (CALERIE legacy study), University of Kansas Medical Center, University of Alabama at Birmingham (precision animal modeling, CTSA), University of Texas Health Science Center at San Antonio (RURAL study recruitment), Klein Buendel (fitness app development), Duke University (CALERIE consortium support), Louisiana State University (collaborative analysis and methodology), and others. Pennington's role on these sub-awards typically involves patient recruitment, data collection, specialized assays (metabolic testing, advanced imaging, biochemical analyses), or biostatistical analysis.

Pennington Biomedical Research Center is a child entity of Louisiana State University, which itself is a state government entity and 1862 Land Grant College. Federal contracts are awarded to Pennington Biomedical Research Center as the named awardee; LSU provides the parent institutional infrastructure. The center's federal activity represents only a subset of LSU's broader federal portfolio and differs substantially from LSU's typical contracting vehicle roles. Pennington's specialty—biomedical research in metabolism, nutrition, obesity, diabetes, and aging—is reflected consistently across the grant and contract base, with no federal equipment procurements, IT services, or non-research activities in the recent award footprint. The center operates research cores and facilities (Mass Spectrometry Core, MRI resources, clinical metabolic assessment capabilities, biorepository) that support both its own funded research and collaborative projects with academic and federal partners.